It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
The purpose of the present study was to evaluate the efficacy of chemo-magnetic hyperthermia (MH), a combination of alternating magnetic field (AMF) and superparamagnetic nanoparticles (SPIONs) coated with Polyethylene glycol-Poly(butyl acrylate)-Polyethylene glycol (PEG-PBA-PEG) carrying 5-Fluorouracil (5-Fu), at inducing apoptosis in the human cancer cell lines HT29 and HCT116. This process can be mediated by alterations in the expression of apoptotic effector proteins, including Bax, Bcl-2, cleaved caspase 3&9, and cleaved PARP, which are involved in the intrinsic pathway of apoptosis. For this purpose, the cells were cultured as monolayers. Then both cell lines were treated with 5-Fu/magnetic nanoparticles and magnetic hyperthermia. Finally, the effect of treatment on cancer cells was determined by Western blot analysis and flow cytometry.
Results
Our results showed that combined chemo-magnetic thermotherapy significantly increased the apoptosis in colon cancer cells compared to chemotherapy or hyperthermia alone (P < 0.05). Up-regulation of Bax, cleaved caspase 3&9, and cleaved PARP proteins was indicative of apoptosis induction in cancer cells, which are involved in the intrinsic pathway of apoptosis.
Conclusions
This study demonstrates that localized hyperthermia was able to significantly trigger the 5-Fu release and inhibit cell viability, which, due to the synchronization of hyperthermia and chemotherapy, exacerbated the damage of cancer cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Iran University of Medical Sciences, Student Research Committee, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066); Iran University of Medical Sciences, Department of Medical Physics, School of Medicine, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066)
2 Iran University of Medical Sciences, Finetech in Medicine Research Center, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066); Iran University of Medical Sciences, Department of Medical Physics, School of Medicine, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066)
3 University of Tehran, Department of Polymer Chemistry, School of Chemistry, College of Science, Tehran, Iran (GRID:grid.46072.37) (ISNI:0000 0004 0612 7950)
4 Iran University of Medical Sciences, Department of Hematology and Blood Transfusion, Faculty of Allied Medicine, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066)
5 Iran University of Medical Sciences, Finetech in Medicine Research Center, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066)
6 Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066)